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Abstract 
 
Cadmium is a metal used in various industrial applications, whereby exposure to Cd-
containing fumes is likely. The submicron sized particles in the fumes represent an extra risk 
due to their high mobility within the organism and high surface area. Toxicity of Cd on the 
liver, kidney and bones is well known, but there are less data on its neurotoxicity. Here, male 
Wistar rats were treated for 3 and 6 weeks by intratracheal instillation of CdO2 
nanosuspension. The treated rats’ body weight gain was significantly decreased, and in the 
high dose rats (0.4 mg/kg Cd daily) the weight of lungs and thymus was significantly 
increased. In this group, the spectrum of spontaneous cortical electrical activity was shifted to 
higher frequencies, the latency of sensory evoked potentials was lengthened, and the 
frequency following ability of the somatosensory evoked potential was impaired – even 
without detectable Cd deposition in the brain. The data support the role of the nano-sized Cd 
in the causation of nervous system damage and show the possibility of modeling human 
neurotoxic damage in rats. 
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Introduction 
 
Environmental conditions constitute one of the four major determinants of human health, and 
the medium causing the most direct exposure to harmful substances is air. Airborne 
particulate matter can be classified as sedimenting dust (>10 µm), suspended or fine dust (100 
nm-10 µm; often called PM10) and ultrafine dust or nanoparticles (NPs, <100 nm). 
NPs as pollutants arise mainly from combustion and other high temperature processes 
(smeltimg, casting, welding of metals, etc.: Antonini et al., 2003). Another potential source of 
exposure to NPs today is nanotechnology. Manufactured nanomaterials are present in 
numerous consumers’ goods and in technical applications (Oberdörster et al., 2005). Quantum 
dots, novel nanotechnological materials (with application, among others, in biomedical 
research) often contain cadmium (more precisely, CdTe) and show special toxicological 
properties (Rzigalinski and Strobl, 2009). Cd-containing metal dust and fumes, or paint spray, 
cause occupational airborne exposure in manufacturing and application of e.g. steel and other 
alloys, pigments and semiconductor materials (ATSDR, 2008). 
Inhaled NPs are either deposited in the nasopharynx or get down to the alveoli (ICRP, 1994). 
Once deposited, NPs translocate readily to other body parts and reach target organs by 
different transfer routes and mechanisms, including transcytosis (by caveola formation) across 
epithelia of the respiratory tract into the interstitium (Oberdörster et al., 2005) and axonal 
transport along the olfactory fibers directly into the CNS (Calderon-Garciduenas et al., 2002). 
Due to their small size, high number concentration, and large specific surface area, NPs have 
greater biological activity per given mass than larger particles (Oberdörster et al., 2005), 
including oxidative stress induction (Li et al., 2003). In the target organs, the components of 
the NPs also exert their own toxic effects, after transport to these sites in whole or after being 
dissolved from the surface of the NPs (Lundborg et al. 1985). Cadmium, in airborne forms, is 
absorbed from the respiratory tract in 2-50%, depending primarily on particle size (Chaney et 
al., 2004). Its several target organs include the lungs, liver, kidney, testis, placenta, as well as 
the nervous system (ATSDR, 2008). Concerning the latter, the reported consequences of 
chronic Cd exposure include amyotrophic lateral sclerosis, optic nerve damage, striatal 
damage and peripheral polyneuropathy (Bar-Sela et al., 2001; Fern et al., 1996; O’Callaghan 
and Miller, 1986; Viaene et al., 1999). In children, a straight relationship between hair Cd and 
altered visual or auditory evoked potential parameters was found (Thatcher et al., 1984), and 
school behavioral problems were reported (Marlowe et al., 1985). Similar effects were 
observed in rats (Agar et al., 1999). In our previous works, several weeks oral application of 
Cd to rats resulted in altered electrocorticogram (ECoG) power spectrum, and in changes of 
cortical evoked potentials and peripheral nerve action potentials (Papp et al., 2003; Institóris 
et al., 2002). In the present work, a potentially more realistic way of exposure – intratracheal 
application of CdO2 NPs – was chosen, and the general toxicological and electrophysiological 
measurements were supplemented with some biochemical ones. 
 
 
Materials and Methods 
 
Animals and treatment 
Adult male Wistar rats of 320-350 g body weight were obtained from the breeding centre of 
the university, and were housed under standard conditions (22 - 24ºC, 12-hour light/dark 
cycle with light on at 06:00) with free access to tap water and standard pellet. The rats were 
divided into 4 groups of 20 animals each at start. 
Cadmium dioxide NPs were synthesized at the Department of Applied Chemistry by a dry 
process. Stochiometric amount of CdCl2 and Na2CO3 were put, in NaCl matrix, in the drum of 
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a planetary ball mill and rotated with stainless steel 20 mill balls at 400 rpm for 4 hours 
(reaction 1: CdCl2 + Na2CO3 → CdCO3 + 2 NaCl). The mixture milled this way was then 
calcined at 480 °C for 4 hours in air (reaction 2: CdCO3 + ½ O2 → CdO2 + CO2). After 
calcination, the synthesis mixture was filtered (0.45 μm PTFE membrane filter) and washed 
with 80°C preheated water to remove any unreacted starting material and the soluble NaCl 
matrix. The precipitate was dried at 100 °C for 1 h and characterized with X-ray diffraction 
and transmission electron microscopy. The size distribution and electron micrograph of the 
CdO2 NPs is shown in Fig. 1. 
 
 
Figure 1 
Size distribution histogram (A) and electron micrograph (B) of the CdO2 nanoparticles. 
Scalebar: 100 nm. 
 
The synthesized NPs were suspended in distilled water, and were instilled into the rats' 
trachea, in daily doses shown in Table 1, five days a week (Monday to Friday). The volume 
instilled was 1 ml/kg b.w. Treatment was continued for 3 and 6 weeks, whereby 10 rats from 
each group were sacrificed after 3 weeks treatment, and the remaining 10 after 6 weeks. There 
was an untreated control group (Con), and a vehicle control group (W). The choice of doses 
was influenced by literature data and by the technically possible concentration of the NPs in 
the distilled water medium. 
 
Table 1 Treatment groups and doses. 
Group Code Treatment and dose Duration 
Untreated control Con --- 
3 and 6 weeks
a
 
Vehicle control W 
Distilled water 
1 ml/kg b.w. 
Low dose LD 
CdO2 nanosuspension, 
0.04 mg Mn/kg b.w.; 1 ml/kg b.w. 
High dose HD 
CdO2 nanosuspension, 
0.4 mg Mn/kg b.w.; 1 ml/kg b.w 
a 
There were 20 rats in each group at start. Ten of them were processed and sacrificed after 3, 
and the another ten, after 6 weeks treatment. 
 
Calculating with ca. 0.5 m
3
/kg b.w. daily breathing volume for the rats (based on data by 
Strohl et al. 1997), our lower dose is comparable to that reported from industrial settings (ca. 
 5 
30 μg/m3, indoors in car body repair shops: Vitayavirasuk et al., 2005; or 1-19 μg/m3, 
outdoors in bridge maintenance: Conroy et al., 1995), and the higher one, to the 550 μg/m3 
used by Takenaka et al. (2004) in a rat inhalation experiment. A more direct comparison is, 
however, impossible because the unknown retention fractions. 
Intratracheal instillation was done in diethyl ether anesthesia, with the rat suspended on a 60° 
inclined board so that its upper incisors were held by a wire loop to keep the animal’s mouth 
open. The trachea was illuminated transdermally. The tongue was pulled forward with a pair 
of non-traumatic forceps, and a custom-made laryngoscope was used to visualize the glottis. 
The nanosuspension (or distilled water for group W) was instilled into the trachea by means 
of a syringe and 1.2 mm OD plastic tubing, inserted between the vocal chords. The untreated 
control group (Con) had neither ether anesthesia nor instillation, while the water control (W) 
group was anesthetized and instilled with distilled water. The nanosuspension was vigorously 
sonicated before, and repeatedly during, administration to prevent agglomeration. 
 
General toxicological and biochemical measurements 
Body and organ weights were the endpoints for general toxic effect of the CdO2 NPs. The 
rats’ body weight was measured each workday during the treatment period, and the mean 
body weight of the groups was plotted against time to see the course of weight gain. 
Following electrophysiology (see below), the rats were sacrificed by an overdose of urethane, 
dissected, and the organ weight of the brain, liver, lungs, heart, kidneys, spleen, thymus and 
adrenals was measured. Relative weights were calculated by relating organ weights to brain 
weight. To reduce costs, 5 of the 10 rats from each group were randomly assigned for 
chemical measurements. Of these, blood, brain, lung and liver samples were taken and stored 
at -22°C. 
Metal level was determined from ca. 1 g of the samples, dried at 80°C to constant weight and 
digested in 5 ml 65 % HNO3 at 90°C for 90 min. After filtration and dilution, metal level was 
determined by inductively coupled plasma mass spectrometry (at the laboratory of the MOL 
Hungarian Oil and Gas Company). 
For biochemical measurements, another 1 g of the samples was homogenized with 4 ml saline 
and centrifuged under cooling for 10 min at 5000 rpm. The supernatant was centrifuged again 
for 20 minutes at 14,000 rpm. 
From the supernatant, protein content was measured according to Lowry et al. (1951). As 
oxidative stress indicators, reduced glutathion (GSH) was measured by the method of Sedlak 
and Lindsey (1968), based on the reaction of non-protein bound SH groups with the Ellman 
reagent (DTNB), was used. Another oxidative stress parameter, superoxide dismutase (SOD) 
activity, was measured by the method of Misra and Fridovich (1972), modified by Matkovics 
et al. (1982), based on inhibition of the spontaneous adrenaline-adrenochrome transformation. 
 
Electrophysiological measurements 
Electrophysiological recording was done 1-3 days after the last instillation. In urethane 
anesthesia the animal's head was fixed and the sensory areas of left hemisphere were exposed. 
The wounds were sprayed with 10% lidocaine, and a thin layer of petroleum jelly was applied 
on the dura to prevent drying. After 30 minutes recovery, silver electrodes were placed on the 
primary somatosensory (SS), visual (VIS) and auditory (AUD) areas. Electrocorticogram 
(ECoG) was recorded from these areas for 6 minutes, and the relative spectral power of the 
frequency bands (delta, theta, alpha, beta1, beta2, gamma; standard human EEG bands) was 
determined. Then, sensory evoked potentials (EPs) were recorded by the same electrodes. For 
SS stimulation, 2 needles were inserted into the contralateral whiskery skin to deliver square 
electric pulses (3-4 V, 0.05 ms, 1-10 Hz). VIS stimulation was produced by a high-luminance 
white LED aimed directly at the rat's right eye, driven by 0.2 ms pulses at 1 Hz. The AUD 
 6 
stimuli were clicks (1 Hz, 40 dB) guided from a miniature earphone into the animal's right ear 
via the hollow ear bar. Fifty stimuli of each modality per rat were applied and the EPs 
recorded. After averaging, latency and duration of the EPs was measured manually (for 
details, see Lukács and Szabó, 2007). The change of latency of the SS EP with increasing 
stimulation frequency was also investigated as a possible indicator of the action of the 
treatment on the state of the cortex. All electrophysiological recording and analysis was done 
by means of the Neurosys 1.11 software (Experimetria Ltd, Budapest, Hungary). The study 
was approved by the Ethical Committee for the Protection of Animals in Research of the 
University. During the whole procedure, the principles of the Committee (based on the EU-
conform Hungarian law) were strictly followed. 
 
Data processing 
From the data, group means ( SD) were calculated. The results were tested for significance 
with one-way ANOVA and the post hoc analysis was done by Scheffe’s test. 
 
 
Results 
 
Body and organ weights 
Intratracheal exposure by the nanoparticulate CdO2 had marked effect on the rats’ body 
weight gain. As shown by Fig. 2, the untreated controls’ (Con) weight gain was undisturbed. 
In the vehicle control (W) group (anesthesia and instillation but no CdO2 NPs) the weight gain 
was lower, and with the advance of time became more and more similar to that seen in the 
treated rats. In the HD group, there was hardly any weight increase in the first weeks. Then, 
some compensation seemed to take effect and the weight gain was similar to that seen in the 
LD group and approached that of the vehicle control (W). 
 
 
Figure 2 
Body weight gain of the treated and control rats over the 6 weeks treatment period. Always 
the data from the first workday of the corresponding week are plotted. 
Mean+SD, n=10. Insert: group codes, see Table 1 for explanation. 
*, **, ***: p<0.05, 0.01, 0.001 vs. Con; 
##
, 
###
: p<0.01, 0.001 vs. W. 
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The relative weight of the lungs was significantly higher in the HD group vs. Con after 6 
weeks exposure (Table 2). In the W and LD groups, there was no noteworthy increase. There 
was also significant increase of the relative thymus weight in the HD group, and decrease of 
the relative spleen and liver weight in the treated groups. After only 3 weeks treatment (not 
shown) the trends were similar but less expressed. 
Brain weight itself was little influenced by the Cd NP treatment (after 6 weeks exposure: Con, 
1.278±0.054 g; W, 1.156±0.91 g; Cd-LD, 1.169±0.091 g; Cd-HD, 1.189±0.134 g) – so the 
relative organ weights were not biased. 
 
Table 2 Relative organ weights after 6 weeks exposure to Cd nanoparticles. 
Groups 
Organs 
Con W Pb-LD Pb-HD 
Lungs 0.787±0.067 0.692±0.084 0.831±0.088 1.359±0.254***### 
Liver 7.323±0.718 7.198±1.071 6.549±0.502* 6.198±0.595 
Kidney 1.407±0.070 1.350±0.089 1.311±0.172 1.379±0.146 
Heart 0.583±0.031 0.542±0.043 0.558±0.039 0.556±0.066 
Spleen 0.468±0.062 0.358±0.040 0.334±0.056*** 0.387±0.041** 
Thymus 0.213±0.026 0.194±0.033 0.207±0.017 0.277±0.056**## 
Adrenals 0.028±0.008 0.027±0.007 0.029±0.008 0.029±0.008 
Mean±SD, n=10. 
*, **, ***: p<0.05, 0.01, 0.001 vs. Con; 
##
, 
###
: p<0.01, 0.001 vs. W. 
 
Cadmium levels and oxidative stress indicators 
A shown by data in Table 3, most of the Cd content of the instilled NPs was located in the 
lungs but a significant amount was absorbed and deposited in the liver in a dose-dependent 
manner. In the brain (and blood) however, no Cd was detected.  
SOD activity was affected neither in the brain nor in the lung and liver (in which organs Cd 
deposition was detected). The level of GSH was, on the contrary, dose-dependently 
influenced and the HD vs. W difference was significant in the lungs and the brain. 
 
Table 3 Cd deposition and reduced glutathione level in tissue samples of rats after 6 weeks 
exposure by CdO2 NPs. 
 Treatment groups 
 W Cd-LD Cd-HD 
Cd level (μg/kg)    
Brain    0  0 0 
Liver  26±26    683±271**    9986±4171**## 
Lung  1707±1391  43020±23904* 268399±199844*# 
GSH (μM)    
Brain 0.0895±0.0037 0.0914±0.0075          0.1071±0.0035***### 
Liver 0.0729±0.0040 0.0806±0.0065            0.1062±0.0020 
Lung 0.2080±0.1780 0.2398±0.1335          0.1681±0.1620***### 
Mean±SD, n=5. *, **, ***: p<0.05, 0.01, 0.001 vs. W; #, ##, ###: p<0.05, 0.01, 0.001 vs. Cd-LD. 
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Electrophysiological effects 
The alterations of the spontaneous cortical activity (ECoG) were alike in all three cortical 
areas. There was a dose- and time-dependent shift from slower to faster waves which became 
significant in the HD group after 6 weeks exposure (Fig 3). After 3 weeks only, no significant 
changes were seen. 
The SS EP showed significant latency increase in the HD group vs. Con at each stimulation 
frequency (Fig. 4). The slight dependence of the latency on the frequency of stimulation, seen 
in Con and W, was more expressed in the treated groups, up to the significant difference 
between the latencies obtained with 1 and 10 Hz stimulation in the HD group. The latency of 
the VIS EP, and to a lesser extent of the AUD EP, also increased in the treated groups vs. Con 
(Fig. 5). 
 
 
 
 
Figure 3 
Band power spectrum (delta to gamma, see insert) of the rats’ electrocorticogram after 6 
weeks exposure. 
Abscissa: group codes. SS, somatosensory area; VIS, visual area; AUD, auditory area. 
*: p<0.05 vs. Con; 
#
: p<0.05 vs. W. 
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Figure 4 
Latency of the somatosensory evoked potential after 6 weeks exposure. 
Abscissa: group codes. Mean+SD, n=10. Insert: stimulation frequency. 
*: p<0.05 vs. Con; °: p<0.05 vs. 1 Hz stimulation within the same treatment group. 
 
 
 
Figure 5 
Latency of the visual and auditory (see insert) evoked potential after 6 weeks exposure. 
Abscissa: group codes. Mean+SD, n=10. 
*, **: p<0.05, 0.01 vs. Con. 
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Discussion 
 
The metal levels, as well as the electrophysiological and biochemical changes, indicated that 
cadmium instilled into the rats’ trachea in form of CdO2 NPs was in fact absorbed from the 
airways and unfolded its toxicity. The time trend of body weights and the increase of 
alterations after 6 vs. 3 weeks suggested a gradual build-up of Cd. Absorption of the metal via 
the airways has been described repeatedly. Takenaka et al. (2004) detected Cd in the blood, 
liver and kidney of rats after inhalation cadmium oxide NPs – in an experiment with much 
shorter duration, and faster tissue sampling after exposure than it was in our work, which may 
explain the main difference viz. the absence of detectable Cd level in our treated rats’ blood. 
In bulk, Cd oxide is hardly water soluble but its absorption from the lung is rather good 
(Oberdörster, 1979). No detectable blood Cd level in our work probably meant that the 
absorbed amount was promptly sequestered in the liver where it was detected in fact. In the 
study by Dill et al. (1994) the blood Cd level after ca. 3 months inhalation exposure by CdO 
particles of about 1 μm diameter was 103 times lower than in the kidney, the other organ 
known to accumulate Cd in the organism. The absence of noteworthy amounts of Cd in the 
blood was, logically, the reason for not detecting Cd in our brain samples. Beyond that, Cd is 
known to have low permeability across the blood-brain barrier (ATSDR, 2008) and no 
transneuronal movement from the periphery to the brain (Tjälve et al., 1996). 
In spite of the latter, neurotoxicity of Cd in humans has been reported repeatedly (see 
Introduction). In exposed workers, elevated urine Cd level was associated with reduced 
visuomotor performance and difficulties of concentration and stance (Viaene et al., 2000), and 
with peripheral neuropathy (Viaene et al., 1999). In children, the exposure indicator was hair 
Cd, and the outcomes, cortical EPs (Thatcher et al., 1984) and behavior (Marlowe et al., 
1985). The significant change in the latency of cortical EPs in our work, without detectable 
Cd deposition in the CNS, was probably due to secondary effects. Along the peripheral part of 
the afferent pathways, Cd
2+
 ions, if present, could interfere with ion channels (primarily Ca-
channels: Viarengo and Nicotera, 1991), and with mitochondrial energy production (López et 
al., 2006), resulting in delayed arrival of the excitation to the subcortical and cortical centers, 
and so to lengthened cortical EP latency. Cd-induced liver damage could affect the substrate 
supply for synthesis of monoamine transmitters (Yourdaydin et al., 1990), the abnormal 
activity of which is known to alter cortical electrical activity (Sebban et al., 1999). The ECoG 
shift in the present study was similar to that found with oral application of dissolved Cd for 12 
weeks (Papp et al., 2003). 
The oxidative stress inducing effect of Cd is indirect; due, among others, to depletion of GSH 
(Valko et al., 2005) and to mitochondrial damage (López et al., 2006). In our treated rats’ 
lungs (the organ having the highest Cd load) GSH level was in fact significantly reduced. The 
increase in the brain samples was possibly of compensatory nature. Others, e.g. Tandon et al., 
(2003) found depletion of GSH in Cd-exposed rats but in that experiment Cd was applied per 
os in dissolved form, in higher dose (1.5 mg/kg b.w.) and was detected in brain samples after 
5 days treatment. 
In spite of some disagreements with others’ findings it can be stated that the data, presented 
above, emphasize the role of the nano-sized fraction of Cd-containing industrial fumes in the 
causation of nervous system damage, and show that it is possible to model the human 
neurotoxic damage caused by inhalational Cd exposure in rats. 
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